Cerity Partners
DNLI icon

Cerity Partners’s Denali Therapeutics DNLI Stock Holding History

Cerity Partners’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,127
Closed -$349K – 1722
2023
Q1 		$349K Buy
+15,127
New +$349K ﹤0.01% 1460